Page last updated: 2024-08-26

bosentan anhydrous and Hepato-Pulmonary Syndrome

bosentan anhydrous has been researched along with Hepato-Pulmonary Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Halank, M; Hoeffken, G; Kolditz, M; Miehlke, S	1

Reviews

1 review(s) available for bosentan anhydrous and Hepato-Pulmonary Syndrome

Article	Year
[Portopulmonary hypertension]. Zeitschrift fur Gastroenterologie, 2005, Volume: 43, Issue:7 Topics: Administration, Inhalation; Administration, Oral; Antihypertensive Agents; Bosentan; Epoprostenol; Hepatopulmonary Syndrome; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Infusions, Intravenous; Lung; Pulmonary Wedge Pressure; Sulfonamides; Survival Rate; Treatment Outcome; Vascular Resistance; Vasodilator Agents	2005

Article

Year

[Portopulmonary hypertension].

Zeitschrift fur Gastroenterologie, 2005, Volume: 43, Issue:7

Topics: Administration, Inhalation; Administration, Oral; Antihypertensive Agents; Bosentan; Epoprostenol; Hepatopulmonary Syndrome; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Infusions, Intravenous; Lung; Pulmonary Wedge Pressure; Sulfonamides; Survival Rate; Treatment Outcome; Vascular Resistance; Vasodilator Agents

2005